What is the recommended management for a child with Reye syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Reye Syndrome in Children

Reye syndrome requires immediate intensive care management focused on controlling intracranial pressure (ICP), correcting metabolic derangements (particularly hypoglycemia and hyperammonemia), and providing aggressive supportive care in a pediatric ICU setting.

Immediate Recognition and Diagnosis

  • Suspect Reye syndrome in any child with persistent vomiting (>12 hours) following a viral illness (influenza or varicella) within the preceding 1-2 weeks, especially if associated with lethargy or altered mental status 1
  • Obtain immediate SGPT (alanine aminotransferase) which is clearly elevated in most cases 1
  • The clinical presentation is stereotypical: lethargy, obtundation, persistent vomiting, agitated delirium progressing to coma 2
  • Death results from severe cerebral swelling with elevated intracranial pressure 2

Critical Initial Management (Stage I Non-Comatose Cases)

Early diagnosis and immediate intravenous treatment of Stage I cases is essential to prevent progression 1

Metabolic Correction (First Priority)

  • Correct hypoglycemia immediately with glucose infusion 3
  • Correct hypocalcemia 3
  • Monitor and treat hyperammonemia aggressively 4

Airway and Respiratory Management

  • Ensure adequate airway care is essential 5
  • Consider early intubation and mechanical ventilation for Stage 3 or higher coma 5
  • Use lung-protective ventilation strategies 3

Intracranial Pressure Management (Stages 3-4)

Continuous intraventricular ICP monitoring is useful for patients in Stage 3 or 4 coma where mortality remains high 5

ICP Control Protocol

  • Treat elevated ICP promptly before clinical signs of deterioration appear 5
  • Use paralytic agents to reduce pressure secondary to muscle movement 5
  • Titrate minimum effective dose of mannitol carefully 5
  • Release small amounts of cerebrospinal fluid for sudden pressure changes 5
  • The multifaceted approach aimed at correcting metabolic derangements and combating intracranial hypertension can result in complete recovery from severe cases 4

Advanced Support for Refractory Cases

Hemodynamic Support (if shock develops)

  • Follow ACCM-PALS guidelines for septic shock management if hemodynamic instability occurs 3
  • Begin with 20 mL/kg isotonic crystalloid boluses over 5-10 minutes, avoiding fluid overload that causes hepatomegaly or rales 3
  • Initiate inotropic support if fluid-refractory 3

Renal Replacement Therapy for Severe Hyperammonemia

  • Consider continuous venovenous haemodialysis (CVVHD) or hybrid therapy (HD followed by CVVHD) for severe hyperammonemia 6
  • One case series showed successful reduction of ammonia from >1,010 μg/dL to <340 μg/dL using HD followed by CVVHD in a patient with Reye syndrome 6
  • Target ammonia reduction to <200 μmol/L (340 μg/dL) 6

Critical Caveats and Prevention

Aspirin Association

  • The use of salicylates (aspirin/acetylsalicylic acid) in children with varicella or influenza-like illnesses is associated with increased risk of developing Reye syndrome 7
  • Avoid all aspirin-containing products in febrile children and teenagers <18 years of age 8, 9, 10
  • Government health warnings regarding aspirin use have resulted in remarkable decline in case numbers 10

Differential Diagnosis

  • Investigate for inborn errors of metabolism in any child with suspected Reye syndrome, as Reye-like syndromes from metabolic defects (particularly medium-chain acyl-CoA dehydrogenase deficiency and other fatty acid oxidation defects) present identically 11
  • True Reye syndrome is now extremely rare; most cases represent metabolic disorders 11, 9

Monitoring and Supportive Care

  • Monitor drug toxicity labs closely as drug metabolism is reduced, putting children at greater risk of adverse drug-related events 3
  • Control hyperglycemia to <180 mg/dL with insulin, but always accompany with glucose infusion 3
  • Provide enteral nutrition if tolerated, otherwise parenteral feeding 3
  • Use sedation with defined goals in mechanically ventilated patients 3

Prognosis

  • Overall mortality is now 20-30% with appropriate intensive care, compared to nearly universal fatality in early reports 12
  • Good outcomes depend on recognition of early manifestations and appropriate stage-based initial therapy 12
  • Complete recovery is possible even from severe cases with aggressive management 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.